NEW DIRECTIONAL CALL PLAYS

Alexion Pharma. - ALXN - close: 100.05 change: +1.73

Stop Loss: 97.95
Target(s): 107.50
Current Option Gain/Loss: Unopened
Time Frame: 2 to 4 weeks
New Positions: Yes, see below

Company Description

Why We Like It:
Biotech stocks are showing strength again and shares of ALXN are poised to breakout from their recent sideways consolidation. The high today was $100.55. I am suggesting a trigger to buy calls at $100.75. If triggered our target is $107.50 but we may have to exit early once we learn when ALXN's earnings report is due. We do not want to hold over the company's announcement but there is not confirmed release date yet.

Trigger @ 100.75

- Suggested Positions -

buy the May $105 call (ALXN1318E105) current ask $2.55

Annotated Chart:

Entry on April -- at $---.--
Average Daily Volume = 1.58 million
Listed on April 10 2013